Trademark Attorney / Law Firm
Charles Valente – Trademark Portfolio
Charles Valente specializes in Class 10 (Medical Apparatus) trademark filings before the United States Patent and Trademark Office (USPTO), with 12 of 16 total filings concentrated in this category. The practice also covers Class 6 (Metal Goods) along with 7 other Nice Classification classes. Filing activity spans from 2022 to 2024. Currently, 12 trademarks are registered.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Charles Valente's trademark practice covers 7 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Common metals and their alloys; metal building materials; transportable buildings of metal
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademark applications has Charles Valente filed?
Charles Valente has filed 16 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 12 registered, 4 abandoned.
What trademark classes does Charles Valente specialize in?
Charles Valente has filed trademarks across 7 Nice Classification classes. The most common practice areas include Class 10 (Medical Apparatus), Class 6 (Metal Goods), Class 40 (Treatment & Processing), Class 11 (Environmental Control), Class 37 (Building & Construction). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
How long has Charles Valente been filing trademarks?
Charles Valente's trademark filing history with the USPTO spans from 2022 to 2024, covering 2 years of trademark practice. During this period, Charles Valente has handled 16 trademark applications.
What is Charles Valente's trademark registration success rate?
Charles Valente has a 75% trademark registration rate, with 12 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.